Epithalon and Geroprotective Properties This study(13) was conducted on 266 elderly subjects (over the age of 60 years) over a period of 6 to 8 years, where some subjects were presented with peptide-bioregulator Thymalin , others with Epithalon, and the rest with the combination of the two
Outperforms omeprazole in several models
Both peptides go into solution at the 1:1 mass ratio, so working-concentration aliquots carry the combined formulation rather than either peptide independently
It is also being investigated for cognitive benefits and improved metabolic function in experimental settings
But is it truly safe for daily consumption
At Formation, a regenerative medicine clinic in Tampa, peptide therapy is administered by Jeff Atlas, PA-C